Offerings

Gather-ed addresses the challenges of traditional health professional educational models through a focus on collaborative, peer-based, efficient educational process delivering formative and enjoyable learning experiences. Check out our current offerings!

Integrating Continuous Glucose Monitoring Into Diabetes Care: Meaningful Engagement for Improved Patient Outcomes

This CME/CE-certified curriculum has been developed to establish impactful small group interactions between members of the diabetes care team that will, through a variety of collaborative educational experiences, help them to fully integrate CGM into daily practice.

3.0 CME/CE

Oncology Innovations: Metastatic Non-Small Cell Lung Cancer

This interactive program updates learners on the latest guideline recommendations for biomarker identification and application in NSCLC. The program will enable learners to select appropriate personalized treatment pathways based on the tumor profile, while incorporating the latest scientific advances applicable to a broad range of patients with PD-L1–positive NSCLC.

3.0 CME/CE

A Comprehensive Approach to Optimizing Glycemic Control

This curriculum will help you to improve the use of continuous glucose monitoring and connected pens, to improve PPG management and time in range control.

3.0 CME/CE

Eye-Connect: Optimal Management of Diabetic Retinopathy: Leveraging the Treatment Evidence

This activity provides guidance for treatment of DR/diabetic macular edema (DME) with anti-VEGF agents, strategies to reduce anti-VEGF treatment burden (eg, treat-and-extend dosing, high-dose and novel agents, and novel products), and highlights the need for individualized treatment and shared decision-making in DR treatment.

3.0 CME/CE

Targeting Mealtime Glucose Excursions and Glycemic Control in T2DM - How and When Should We Use Newer Insulins?

This curriculum will comprehensively review key information and best practices to help clinicians formulate their own practice action plans in the care of patients with T2DM who are candidates for mealtime insulin.

3.50 CME/CE

New Directions in Atopic Dermatitis Management: Harnessing the Power of Social Learning to Improve Patient Outcomes

This collaborative social learning platform establishes a network of providers who can support each other locally, as well as those from different communities, with the goal of learning and sharing best practices that will improve outcomes for patients with Atopic Dermatitis.

2.50 CME/CE

Improving Management of Advanced Non-Melanoma Skin Cancer

This course will allow you to better identify patients at high risk for NMSC, enhance your understanding of multiple models of screening and staging for NMSC in immunosuppressed and other patients at elevated risk, and strengthen your shared decision-making skills when communicating with your patients.

3.00 CME/CE

Improving the Care of Patients with Advanced Renal Cell Carcinoma

3.75 CME/CE

Networks in Neurology: A Virtual Collaboration of Specialists and Practicing Neurologists on the Effective Integration of New Agents and Strategies for Multiple Sclerosis

This curriculum will help you improve your multiple sclerosis management skills by distilling the most relevant and valuable information for your patients.

3.25 CME/CE

Making Sense of Rapidly Evolving Management Approaches in Multiple Myeloma - Virtual Study Groups

This curriculum will give you the opportunity to delve deeply into Multiple Myeloma diagnosis, workup, risk assessment, treatment, and patient care.

1.25 CME/CE

Treating Hepatitis C in the Primary Care Setting

This curriculum will enhance your competence and confidence in treating patients with chronic hepatitis C virus infection.

4.25 CME/CE

Improving Beta-thalassemia Outcomes

This curriculum will present you with key topics including disease fundamentals, transitioning patients to adult care, new and emerging therapies, and issues around transfusion in order to improve disease management and care coordination and yield better outcomes for patients with Beta-thalassemia.

2.75 CME/CE

Opioid Analgesic Risk Evaluation and Mitigation Strategy for Hackensack Meridian Health and Thomas Jefferson University College of Population Health

Pulmonary Arterial Hypertension (PAH) is a progressive disease and is associated with poor clinical outcomes. Data from the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) has shown that the diagnosis of PAH is often missed or delayed with the average length of time from symptom onset to diagnosis estimated to range from 1 to 3 years.

Meeting the Challenge of Pain Management in an Ever-Evolving Opioid Epidemic

This curriculum will give you the opportunity to build foundational knowledge on chronic rhinosinusitis with nasal polyps with respect to patient quality of life, disease progress, and underlying immunologic processes. In addition, you will reviews the efficacy and safety of standard and novel treatment options.

4.5 CME/CE

Improving Outcomes and Quality of Life in Atopic Dermatitis

This curriculum will enable you to examine the clinical features, immuno-pathophysiology, and impact of AD, and strategies for individualized treatment.

Collaborating To Overcome Lifelong Challenges in Hemophilia A: Prophylaxis, Inhibitors, and Treatment Burden

This curriculum will enable you to be apprised of the latest data on approved and emerging treatments to facilitate patient and caregiver education, improve adherence, and implement personalized treatment plans that balance treatment efficacy and safety.

1.75 CME/CE

Following the Trail of Evidence to Individualize and Optimize Multiple Sclerosis Care

This curriculum will enable you to summarize the latest clinical evidence and recommendations for early diagnosis and aggressive management of MS.

2.0 CME/CE

A Multidisciplinary Team Approach to Patient-Centric Management of Fabry Disease

This curriculum will enable you to engage with focused and up-to-date education on managing this rare and complex disease.

3.75 CME/CE

Optimal Identification and Management of Pulmonary Arterial Hypertension

This curriculum will help you reduce the time to diagnosis and improve medical management of patients with PAH.

2.75 CME/CE

Making Sense of the Evolving Standards of Care for Advanced HER2+ Breast Cancer

This curriculum will help you optimally manage HER2-positive breast cancer patients who have received prior anti-HER2 targeted therapies.

1.0 CME/CE

A Collaborative Approach to IBD Management: Meaningful Engagement for Whole-Patient Care

This curriculum is focused on implementing a collaborative approach in primary care and gastroenterology settings to improve patient care.

3.25 CME/CE

Reaching and Teaching Community-Based Clinicians to Improve Outcomes in CAR T-cell Therapy for DLBCL

This educational program will comprehensively review key information and best practices to help clinicians formulate their own practice action plans in the care of patients with DLBCL.

3.50 CME/CE

Managing BRAF V600-mutant Colorectal Cancer: Harnessing the Power of Social Learning to Improve Patient Outcomes

This educational program will help clinicians understand the importance of BRAF testing and treatment with practical guidance on managing AEs to keep patients on effective doses of their needed medications.

4.0 CME/CE

Mastering the Evolving Treatment Landscape in HER2-Positive Breast Cancer: Current Guidance and Future Perspectives

This curriculum will help improve the knowledge, confidence, competence, and performance of learners in selecting individualized treatment for patients with HER2+ breast cancer.

3.5 CME/CE

Addressing the Complexities of MS Care during COVID: Tapping into the Power of Collaborative Peer-focused Education

3.25 CME/CE

Eye-Connect: Patient-Focused Management of Diabetic Care and Vision Screening and Referral for Diabetic Retinopathy

This curriculum offers practical strategies clinicians can use to empower patients to engage in recommended diabetic eye care (eg, screening, risk factor ), a look at the progressive nature of DR to underscore the importance of early intervention, and an overview of novel screening and diagnostic tools that can be used to expedite care.

3.0 CME/CE

Contemporary Approaches to Relapsed/Refractory Multiple Myeloma

This curriculum will help you apply practice-changing clinical data and expert recommendations, in order to optimize clinical outcomes with BCMA-targeted therapies for patients with relapsed/refractory multiple myeloma.

Osteoarthritis and Pain: Intensive Training in Pain Management

This curriculum will provide you with an enhanced understanding of the physiology and burden of OA pain and the investigational agents that may be beneficial for people who have not had satisfactory relief with other treatments.

3.25 CME/CE

Networks in Neurology: A Virtual Collaboration of Headache Specialists and Practicing Neurologists on the Effective Integration of New Agents and Strategies for Migraine.

This curriculum will help you improve your migraine management skills by distilling what information is most relevant in the evolving world and what it means for patients. It features an in-depth interview with a renowned headache specialist, Dr Shivang Joshi.

2.75 CME/CE

Geographic Atrophy: What to Look For and When to Refer

This curriculum will give you the opportunity to discuss the prevalence of age-related macular degeneration, articulate the burden of illness linked to geographic atrophy, understand the pathogenesis of GA, describe disease detection and factors influencing progression, and review the therapeutic interventions that have been explored as well as those in the pipeline.

2.0 CME/CE

Modernizing Care of Patients with BCC: Changes in Management Approaches

This curriculum will help you optimally manage basal cell carcinoma patients through an interdisciplinary approach.

3.0 CME/CE

Chronic Rhinosinusitis With Nasal Polyps: Considering Systemic Management Approaches to Optimize Outcomes

This curriculum will afford you the opportunity to build foundational knowledge on chronic rhinosinusitis with nasal polyps with respect to patient quality of life, disease progress, and underlying immunologic processes. In addition, you will review the efficacy and safety of standard and novel treatment options.

2.5 CME/CE

Turning Complexity into Clarity in AML

This curriculum will allow you to engage key topics including use of induction therapy in the non-elderly population, treating suboptimal response to induction therapy, best practices for measurable (or minimal) residual disease assessment, and proper use of maintenance therapy in order to improve outcomes for patients with AML.

3.0 CME/CE

Turning Complexity into Clarity in Advanced Cervical Cancer

3.0 CME/CE

Caring for Patients with Atopic Dermatitis: Incorporating Pathophysiology into a Comprehensive Management Plan

This curriculum will enable you to examine the clinical characteristics, the current understanding of immuno-pathophysiology, and the psychosocial and quality of life impact of atopic dermatitis on patients across age groups. In addition, you will review strategies to individualize treatment for patients with atopic dermatitis will be discussed.

2.75 CME/CE

Lighting the Fire: Improving Racial Parity in Oncology

This curriculum will enable you to examine ways to reduce individual and systemic barriers to equity in the delivery of cancer care that impact outcomes for black men and women facing cancer.

3.75 CME/CE

Moving the Needle: Collaborative Strategies to Overcome Barriers to Insulin Initiation and Adherence

This curriculum will enable you to identify patient and clinician barriers to insulin initiation and titration and strategies to address these barriers, evaluating efficacy and safety data for insulin, and developing patient-specific plans for insulin therapy.

3.75 CME/CE

Best Practices in Early-Stage NSCLC

This curriculum will help you optimally manage patients with early Non-Small Cell Lung Cancer.

1.0 CME/CE

Advances in the Multidisciplinary Care of Patients With Tenosynovial Giant Cell Tumor

This curriculum will enable you to identify patients with TGCT and refer to or partner with tertiary care centers for multidisciplinary management, discuss the benefits and risks of available treatment options for localized and diffuse TGCT, and create a collaborative, individualized TGCT treatment plan.